Syros Pharmaceuticals, Inc.【SYRS】 利益剰余金の推移

機能の使い方
(単位:千ドル) 利益剰余金 前年比(%)
3Q24 -756,200 +14.9%
2Q24 -749,800 +21.3%
1Q24 -726,500 +24.8%
4Q23 -722,800 +29.5%
3Q23 -658,400 +19.0%
2Q23 -618,300 +18.2%
1Q23 -582,000 +19.1%
4Q22 -558,200 +20.4%
3Q22 -553,500 +25.9%
2Q22 -523,200 +26.5%
1Q22 -488,700 +24.9%
4Q21 -463,600 +23.0%
3Q21 -439,800 +26.8%
2Q21 -413,700 +26.4%
1Q21 -391,200 +26.1%
4Q20 -377,000 +28.7%
3Q20 -346,900 +27.0%
2Q20 -327,400 +29.2%
1Q20 -310,209 +32.6%
4Q19 -292,983 +34.7%
3Q19 -273,254 +37.0%
2Q19 -253,461 +37.9%
1Q19 -234,006 +37.9%
4Q18 -217,545 +40.1%
3Q18 -199,513 +42.5%
2Q18 -183,776 +45.7%
1Q18 -169,729 +50.5%
4Q17 -155,266 +53.3%
3Q17 -139,964 +55.0%
2Q17 -126,139 +65.7%
1Q17 -112,771 -
4Q16 -101,256 -
3Q16 -90,291 -
2Q16 -76,122 -